Gomera, Alma B.

HRN: 28-42-00  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2026
CO-AMOXICLAV 625MG (TAB)
02/24/2026
03/02/2026
PO
625mg
BID
UTI Following Delivery
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: